2021
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
Gynecologic oncology
鈥�Critical Care Medicine Specialist, Gynecologic Oncologist (Gynecological Cancer Specialist)
81 publications
2021
Gynecologic oncology
鈥�2021
Journal of gynecologic oncology
鈥�2021
Current oncology reports
鈥�2021
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
鈥�2021
Proceedings of the National Academy of Sciences of the United States of America
鈥�